STAGE I DIAGNOSTICS, INC.

Profile

Company Names

STAGE I DIAGNOSTICS, INC.

Addresses

10912 COL. GLENN ROAD, SUITE 500, LITTLE ROCK, AR 72204

401 SOUTH CEDAR STREET, SUITE G42, LITTLE ROCK, AR 72205

4301 WEST MARKHAM STREET, #831, LITTLE ROCK, AR 72205

Phone Numbers

501-353-0014
501-686-6696

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2005

State Incorporated:

ARKANSAS

Total Amount Raised:

$1,100,620.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2018-06-22 
$101,250.00 
$2,500,000.00 
$2,398,750.00 
Equity 
7
2018-04-30 
$219,655.00 
$219,655.00 
$0.00 
Debt 
6
2017-03-31 
$198,215.00 
$500,000.00 
$301,785.00 
Debt 
5
2016-09-19 
$60,250.00 
$95,000.00 
$34,750.00 
Equity 
4
2016-05-25 
$100,000.00 
$500,000.00 
$400,000.00 
Debt 
3
2014-11-13 
$301,250.00 
$700,000.00 
$398,750.00 
Equity 
2
2012-07-31 
$20,000.00 
$2,500,000.00 
$2,480,000.00 
Equity 
1
2009-06-12 
$100,000.00 
$1,000,000.00 
$900,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DON 
FOWLER 
EXECUTIVE OFFICER, DIRECTOR
DON 
E. 
FOWLER 
EXECUTIVE OFFICER, DIRECTOR
GREGORY 
E. 
GARDINER, PH.D 
DIRECTOR
MARY 
L. 
GOOD 
DIRECTOR
MARY 
L. 
GOOD, PH.D 
DIRECTOR
H. 
WATT 
GREGORY, III 
DIRECTOR
CHARLES 
R. 
LINN 
EXECUTIVE OFFICER
MICHAEL 
B. 
MILLER 
EXECUTIVE OFFICER
TIMOTHY 
J. 
O-BRIEN 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
TIMOTHY 
J. 
O-BRIEN, JR. 
DIRECTOR, PROMOTER
TIMOTHY 
J. 
O-BRIEN, PH.D 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
WILLIAM 
W. 
RICHARDSON 
DIRECTOR
DENNIS 
L. 
STEARNS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-06-22 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-04-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-03-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-09-19 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-05-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-11-13 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-07-31 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-06-12 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#